In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Bellerophon Therapeutics, Inc.. Trade Record

NASDAQ:BLPH Bellerophon Therapeutics, Inc. stock gains 8.07% Exit Aug 26, 2015 a Trade Record by priceseries

Trade Chart
Trade Chart BLPH Aug 25, 2015, priceSeries
About Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates include INOpulse, a pulsatile nitric oxide delivery device, which has completed Phase II clinical trials for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

Trade Information
Trade Type
LONG
ReliabilityScore™
75.00
Entry Date
Aug 25, 2015
Entry Price
5.02
Sell Date
Aug 26, 2015
Sell Price
5.42
Net Gain
8.07%
Hold Time
1 Trading Days